Cargando…

SUN-669 The G209R Mutant Mouse as a Model for Human PCSK1 Polyendocrinopathy

A striking number of SNPs and rare mutations have been identified in PCSK1, the gene that codes for the enzyme proprotein convertase 1/3 (PC1/3) which proteolytically activates prohormones within the secretory pathway. All infants bearing two copies of catalytically inactivating mutations, including...

Descripción completa

Detalles Bibliográficos
Autores principales: Shakya, Manita, Gahlot, Surbhi, Arunagiri, Anoop, Hassan, Anis, Arvan, Peter, Low, Malcolm James, Lindberg, Iris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208903/
http://dx.doi.org/10.1210/jendso/bvaa046.913
_version_ 1783530955109040128
author Shakya, Manita
Gahlot, Surbhi
Arunagiri, Anoop
Hassan, Anis
Arvan, Peter
Low, Malcolm James
Lindberg, Iris
author_facet Shakya, Manita
Gahlot, Surbhi
Arunagiri, Anoop
Hassan, Anis
Arvan, Peter
Low, Malcolm James
Lindberg, Iris
author_sort Shakya, Manita
collection PubMed
description A striking number of SNPs and rare mutations have been identified in PCSK1, the gene that codes for the enzyme proprotein convertase 1/3 (PC1/3) which proteolytically activates prohormones within the secretory pathway. All infants bearing two copies of catalytically inactivating mutations, including G209R, exhibit severe neonatal malabsorption requiring parenteral nutrition for months and subsequently develop additional endocrinopathies, often including diabetes and obesity. In order to create a mouse model to explore the underlying mechanism of the malabsorption phenomenon and the endocrinopathies, a G209R point mutation was introduced into exon 6 of mouse Pcsk1 using CRISPR-Cas9 genome editing. Fifty-six live pups were collected at postnatal days one or two; however, most homozygous G209R mutant pups succumbed by day 2, and surviving pups were severely dwarfed. In homozygous, but not heterozygous pups, blood glucose levels were significantly lower with elevated plasma insulin-like immunoreactivity and accumulation of unprocessed proinsulin in G209R pancreas compared to the wild type pups from the same litters. The POMC product α-MSH (produced by PC2 from PC1/3-generated ACTH) has been strongly implicated in obesity mechanisms. We found pituitary POMC processing to ACTH was also affected by the G209R mutation in combined anterior and intermediate pituitary lobes. ACTH was markedly reduced in homozygote pituitary, with significant accumulation of POMC. Using Western blotting, we observed a significant reduction in PC1/3 protein in homozygote brains, while PC2 protein levels remained unaffected. Most likely due to the continued presence of PC2, pituitary and brain levels of α-MSH were not impaired, suggesting that α-MSH itself is not involved in the phenotype. Prior studies have shown that G209R PC1/3 is not efficiently trafficked out of the ER; further studies will examine the contribution of misfolded G209R PC1/3 to possible cellular ER stress, as well as determine peptide hormone levels in brain and peripheral tissues.
format Online
Article
Text
id pubmed-7208903
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72089032020-05-13 SUN-669 The G209R Mutant Mouse as a Model for Human PCSK1 Polyendocrinopathy Shakya, Manita Gahlot, Surbhi Arunagiri, Anoop Hassan, Anis Arvan, Peter Low, Malcolm James Lindberg, Iris J Endocr Soc Diabetes Mellitus and Glucose Metabolism A striking number of SNPs and rare mutations have been identified in PCSK1, the gene that codes for the enzyme proprotein convertase 1/3 (PC1/3) which proteolytically activates prohormones within the secretory pathway. All infants bearing two copies of catalytically inactivating mutations, including G209R, exhibit severe neonatal malabsorption requiring parenteral nutrition for months and subsequently develop additional endocrinopathies, often including diabetes and obesity. In order to create a mouse model to explore the underlying mechanism of the malabsorption phenomenon and the endocrinopathies, a G209R point mutation was introduced into exon 6 of mouse Pcsk1 using CRISPR-Cas9 genome editing. Fifty-six live pups were collected at postnatal days one or two; however, most homozygous G209R mutant pups succumbed by day 2, and surviving pups were severely dwarfed. In homozygous, but not heterozygous pups, blood glucose levels were significantly lower with elevated plasma insulin-like immunoreactivity and accumulation of unprocessed proinsulin in G209R pancreas compared to the wild type pups from the same litters. The POMC product α-MSH (produced by PC2 from PC1/3-generated ACTH) has been strongly implicated in obesity mechanisms. We found pituitary POMC processing to ACTH was also affected by the G209R mutation in combined anterior and intermediate pituitary lobes. ACTH was markedly reduced in homozygote pituitary, with significant accumulation of POMC. Using Western blotting, we observed a significant reduction in PC1/3 protein in homozygote brains, while PC2 protein levels remained unaffected. Most likely due to the continued presence of PC2, pituitary and brain levels of α-MSH were not impaired, suggesting that α-MSH itself is not involved in the phenotype. Prior studies have shown that G209R PC1/3 is not efficiently trafficked out of the ER; further studies will examine the contribution of misfolded G209R PC1/3 to possible cellular ER stress, as well as determine peptide hormone levels in brain and peripheral tissues. Oxford University Press 2020-05-08 /pmc/articles/PMC7208903/ http://dx.doi.org/10.1210/jendso/bvaa046.913 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Diabetes Mellitus and Glucose Metabolism
Shakya, Manita
Gahlot, Surbhi
Arunagiri, Anoop
Hassan, Anis
Arvan, Peter
Low, Malcolm James
Lindberg, Iris
SUN-669 The G209R Mutant Mouse as a Model for Human PCSK1 Polyendocrinopathy
title SUN-669 The G209R Mutant Mouse as a Model for Human PCSK1 Polyendocrinopathy
title_full SUN-669 The G209R Mutant Mouse as a Model for Human PCSK1 Polyendocrinopathy
title_fullStr SUN-669 The G209R Mutant Mouse as a Model for Human PCSK1 Polyendocrinopathy
title_full_unstemmed SUN-669 The G209R Mutant Mouse as a Model for Human PCSK1 Polyendocrinopathy
title_short SUN-669 The G209R Mutant Mouse as a Model for Human PCSK1 Polyendocrinopathy
title_sort sun-669 the g209r mutant mouse as a model for human pcsk1 polyendocrinopathy
topic Diabetes Mellitus and Glucose Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208903/
http://dx.doi.org/10.1210/jendso/bvaa046.913
work_keys_str_mv AT shakyamanita sun669theg209rmutantmouseasamodelforhumanpcsk1polyendocrinopathy
AT gahlotsurbhi sun669theg209rmutantmouseasamodelforhumanpcsk1polyendocrinopathy
AT arunagirianoop sun669theg209rmutantmouseasamodelforhumanpcsk1polyendocrinopathy
AT hassananis sun669theg209rmutantmouseasamodelforhumanpcsk1polyendocrinopathy
AT arvanpeter sun669theg209rmutantmouseasamodelforhumanpcsk1polyendocrinopathy
AT lowmalcolmjames sun669theg209rmutantmouseasamodelforhumanpcsk1polyendocrinopathy
AT lindbergiris sun669theg209rmutantmouseasamodelforhumanpcsk1polyendocrinopathy